Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 26 Aug 2026

Sai Parenterals' Australian OTC supply book reached AU$232 million in total contracted commitments after renewing a three-year AU$30 million supply agreement with a pharmacy chain through its subsidiary Noumed Pharmaceuticals.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Sai Parenterals' Australian OTC supply book reached AU$232 million in total contracted commitments after renewing a three-year AU$30 million supply agreement with a pharmacy chain through its subsidiary Noumed Pharmaceuticals.

cnbctv18.com25 Aug 2026

Sai Parenterals' Australian OTC supply book reached AU$232 million (about ₹1,506 crore) after its subsidiary Noumed Pharmaceuticals renewed a three-year supply agreement worth AU$30 million with a pharmacy chain.

cnbctv18.com25 Aug 2026

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.